Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Biological Variability in Ovarian Cancer Incidence and Severity Mariah Malak Bilalaga MedStar Union Memorial Hospital PLCO Jul 22, 2024 PLCO-1630
Biomarker-assisted Decision Rule for Risk Classification under a positive predictive value - constraint: Application to disease screening Yingqi Zhao Fred Hutchinson Cancer Center PLCO May 14, 2024 PLCO-1556
Biomarkers and genetic polymorphisms of one-carbon metabolism and risk of lymphoid cancers Unhee Lim NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0025
Biomarkers for Head and Neck Cancer Uday Kumbhar Innotech Precision Medicine PLCO Jul 8, 2024 PLCO-1571
Biomarkers of Exposure and Response to Coffee Intake Erikka Loftfield National Cancer Institute PLCO Mar 20, 2020 PLCO-599
Biopsy Recommendation in Prostate Cancer Using Machine Learning Techniques TAHA KHAN FAST-NUCES Karachi PLCO Oct 16, 2017 PLCO-314
Biorepository Robert Garver University of Alabama at Birmingham NLST Jun 6, 2003 2003-90016
Biospecimen collection in the PLCO trial Danielle Carrick Westat PLCO Jul 1, 2006 2006-0024
Bisphosphonates as Chemoprevention Sharon Hensley Alford Henry Ford Health System PLCO Jul 8, 2010 2009-0264
Black Participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Fred L Stallings CDC PLCO Jul 1, 2006 2006-0235
Bladder Cancer Data Visualization OMAR GALDAMEZ CRUZ CENTRO DE DISEÑO Y COMUNICACION, S.C. PLCO Aug 2, 2022 PLCO-1011
Bladder Cancer Incidence and Smoking Adrien Bernstein None PLCO Jul 5, 2016 PLCO-216
Blockchain-based information system for medical image transfer Jianjing Lin Rensselaer Polytechnic Institute NLST May 28, 2019 NLST-515
Blood Analysis-Driven Machine Learning for Ovarian Cancer Detection Ivan Shtepliuk Linköping University PLCO Apr 21, 2025 PLCO-1879
Blood-based biomarkers as a complement to CT screening for lung cancer Edwin Ostrin University of Texas MD Anderson Cancer Center NLST Jul 29, 2020 NLST-698
Blood based biomarkers for early detection of lung cancer in those who have never smoked Edwin Ostrin University of Texas MD Anderson Cancer Center PLCO Jun 12, 2025 2025-0031
Blood-based biomarkers for personalized risk assessment of breast and ovarian cancers Johannes Fahrmann University of Texas MD Anderson Cancer Center PLCO Jul 1, 2023 2022-0048
Blood-based biomarkers for risk assessment and early detection of colorectal cancers Samir Hanash University of Texas MD Anderson Cancer Center PLCO Feb 23, 2023 2022-0046
Blood-based gene expression markers for early detection of lung cancer Melissa Rotunno NCI, DCEG, GEB PLCO Oct 22, 2012 2012-0247
Blood groups and inflammatory marker levels Charles Rabkin DCEG PLCO Jul 17, 2020 PLCO-646